Human immunoglobulin for immunoglobulin G deficiency (Guangxi Beisheng Pharmaceutical)

静脉注射用人免疫球蛋白（PH4）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHuman immunoglobulin for immunoglobulin G deficiency (Guangxi Beisheng Pharmaceutical)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > ImmunoglobulinBiologics > Blood components

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsImmunoglobulin G4-Related Disease

Global Approved IndicationsImmunoglobulin G4-Related Disease

Approved Indications in ChinaImmunoglobulin G4-Related Disease

Original Approved Country/TerritoryMainland China

Original Approved Date2005/01/01

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusWithdrawn

Highest Status in ChinaWithdrawn

China Registration ClassN/A

Active CompaniesN/A

Active IndicationsN/A

Inactive IndicationsImmunoglobulin G4-Related Disease

ATC CodeJ06BA02